John Wiley & Sons, Ltd, 2009. — 321 p. — ISBN 978-0-470-68196-1; ISBN 978-0-470-68197-8.
Feature Boxes
Inorganic Chemistry BasicsCrystal field theoryOctahedral crystal field
Other crystal fields
Factors affecting the crystal field splitting parameter, D
High- and low-spin complexes
Molecular orbital theoryMO diagram of molecular hydrogen
MO diagram for [Co(NH
3)
6]
3þ
Absorption spectra of metal complexesBand intensity/selection rules
Spectroscopic and crystal field terms
Band assignments and D
Magnetic properties of metal complexesReactions of metal complexesForward and reverse rates and equilibrium
Water exchange rates for metal ions
Transition State Theory, the kinetic rate constant and equilibrium
Trans effect and substitution reactions
Stability of metal complexes
Chelate effect
Macrocyclic effect
Hardsoft acidsbases
Further reading
Metallo-Drugs and Their ActionProteins as targets for metallo-drugsProtein structure
Metal binding sites on proteins
DNA as a target for metallo-drugsStructure of DNA and RNA
Metal binding sites on DNA
Reaction of metal complexes in the biological milieuReactions with chloride
Reactions with phosphate
Reactions with carbonate
Evaluating the pharmacological effects of agentsMeasuring the cytotoxicity of a drug
Measuring drug uptake
Animal studies
From discovery to the marketplaceDrug approval process
Profits
Further reading
CisplatinPhysical and chemical properties of cisplatin
Formulation, administration and pharmacokinetics
Reaction of cisplatin in biological media
Uptake, cytotoxicity and resistanceInflux and efflux of cisplatin
Modification by glutathione and metallothionein
DNA repair
Other resistance mechanisms
Interaction of cisplatin with cellular targetsDNA as a target
Non-DNA targets
Further reading
Platinum Anticancer DrugsCarboplatinSynthesis and properties of carboplatin
Formulation, administration and pharmacokinetics of carboplatin
Reactions of carboplatin in the biological milieu
Cytotoxicity and uptake of carboplatin
Interaction of carboplatin with cellular targets
[
b]Oxaliplatin[/b]Stereochemistry of oxaliplatin
Synthesis and properties of oxaliplatin
Formulation, administration and pharmacokinetics of oxaliplatin
Reaction of oxaliplatin in the biological milieu
Cytotoxicity and uptake of oxaliplatin
Interaction of oxaliplatin with cellular targets
New platinum agentsNedaplatin
Lobaplatin
Heptaplatin
Satraplatin (JM216)
Picoplatin (AMD473, ZD473)
BBR
Further reading
Ruthenium, Titanium and Gallium for Treating CancerRuthenium compounds for treating cancerChemistry of ruthenium in the biological milieu
Structure, synthesis and properties of ruthenium antitumor agents
Synthesis and biological properties of NAMI-A
Control of tumor growth by NAMI-A
Clinical trials with NAMI-A
Interaction of NAMI-A with potential biological targets
Synthesis and biological properties of KP
Biological activity of KP
Clinical trials with KP
Interaction of KP1019 with potential biological targets
Synthesis and properties of ruthenium arene compounds
Biological activity of the arene complexes
Targets of the ruthenium arene compounds
Titanium compounds for treating cancerStructure, synthesis and properties of titanocene dichloride
Interaction of titanocene dichloride with potential biological targets
Structure, synthesis and properties of budotitane
Antitumor activity and clinical trials with budotitane
Biological interactions of budotitane
Titanium anticancer drugs in development
Gallium for treating cancerChemistry of gallium in biological media
Structures, synthesis and properties of gallium anticancer agents
Uptake, cytotoxicity and reactivity of gallium agents in the biological system
Gallium anticancer agents in development
Further reading
Gold Compounds for Treating Arthritis, Cancer and Other DiseasesChemistry of gold in biological media
Gold compounds for treating arthritisStructures, synthesis and properties of gold antiarthritic drugs
Formulation, administration and pharmacokinetics of gold antiarthritic drugs
Reactions in biological media, uptake and cytotoxicity of gold drugs
Interactions with cellular targets
Gold complexes for treating cancerStructures, synthesis and properties of gold anticancer agents
Reactions in biological media, uptake and cytotoxicity of gold anticancer agents
Reactions with cellular targets
Gold complexes for treating AIDS and other diseasesFurther reading
Vanadium, Copper and Zinc in MedicineVanadium for treating diabetesDiabetes mellitus (DM)
Bis(ethylmaltolato)oxovanadium(IV), BEOV and
bis(maltolate)oxovanadium(IV), BMOV
Bis(acetylacetonato)oxovanadium(IV), VO(acac)2, bis(picolinato)oxovanadium(IV), VO(pic)2 and oxodiperoxo(1,10-phenanthroline)vanadium(V), [bpV(phen)]
Anticancer effects of vanadium compounds
Role of copper and other metal ions in Alzheimers disease
Metal chelating agents for treating Alzheimers disease
Complexes of the amyloid beta (Ab) peptide
Radical production in AD
Copper in Wilsons and Menkes diseases
Zincbicyclam: a chemokine receptor antagonistFurther reading
Metal Complexes for Diagnosing DiseaseTechnetium in diagnostic nuclear medicineClinically used
99mTc imaging agents
Technetium imaging agents for selective targeting
Innovations in synthesis, the [Tc(CO)
3] þ core
Metal compounds as contrast agents for MRIClinically used MRI contrast agents
Contrast agents in development
Iron oxide particles
Radionuclides for palliative care and cancer treatmentFurther reading
NanomedicineNanoscience for treating diseaseSingle walled carbon nanotubes
Metalorganic frameworks
Mesoporous silica
Encapsulation
Gold nanoparticles
Nanomedicine in diagnosing diseaseComputed tomography
Magnetic resonance imaging
Quantum dots
Potential health risks of nanoparticlesCell culture assays and nanomaterials
Cytotoxicity of nanoparticles
Further reading